Patient-oriented clinical
research has improved in the past twenty years thanks to public investment in
several initiatives (e.g. the creation of clinical trial units (CTUs),
the establishment of the Swiss Clinical Trial Organisation (SCTO),
local clinical MD-PhD programmes, and the Swiss Group for Clinical Cancer
Research (SAKK) regional networks project), infrastructures
(e.g. data warehouses, biobanks, analytic platforms, the Swiss Personalized
Health Network (SPHN), and the Swiss Biobanking platform (SBP)),
and support instruments (e.g. Swiss National Science Foundation (SNSF)
grants for longitudinal studies, funding for investigator-initiated clinical
trials (SNSF’s IICT programme), and the SAMS and Bangerter Foundation’s joint
programme Young Talents in Clinical Research (YTCR)).
However, these efforts have
also led to a fragmentation of activities, and deficits remain – including
limited integration and harmonisation of processes within and between
institutions, insufficient involvement of patients, a lack of incentives to
choose a career in clinical research, weak multidisciplinary and
interdisciplinary research, and uncertain sustainable funding for research
infrastructures and early career researchers. Moreover, despite the high quality of medical care in Switzerland, Swiss
clinical research still lags behind basic and experimental research and behind
clinical research in leading countries when compared internationally.
Written on behalf of the State Secretariat for
Education, Research and Innovation (SERI), the White Paper: Clinical Research analyses the major driving forces that are
transforming clinical research and identifies current weaknesses in clinical
research in Switzerland. Based on the notion that good care comes with – and
from – good science, the white paper calls for a transformation of the
clinical research culture in hospitals and related research institutions so as
to make it more integrative at all levels.
The white paper also provides a roadmap that
outlines the following seven goals and constitutes an action plan for change to
make Switzerland an international leader in patient-centred clinical research:
- Create a national platform to coordinate publicly funded stakeholders in clinical research.
- Establish strong partnerships with society, the public, and patients.
- Promote a healthcare system that systematically integrates clinical research: good care comes with – and from – good science.
- Invest in the development of innovative and dynamic clinical research approaches, designs, and technologies enabled by digital tools.
- Strengthen translational, multidisciplinary, and integrated clinical research teams.
- Create an environment that is attractive to clinical and health researchers and support them at all career levels.
- Increase the efficiency of clinical research
and accelerate its delivery by reducing the complexity of regulatory and
data-related processes.
In
order to increase the benefit of research to society as a whole, patients and
the public should be involved in strategic discussions and funding decisions
related to clinical research. Along with innovation and novelty, evaluation
criteria for research grants should include addressing unmet medical needs and
achieving patient-relevant outcomes. In addition, public campaigns should
emphasise both the value of partnerships between scientists, patients, and the
public and the importance of clinical research for high-quality healthcare.
Moreover, initiatives to create a national framework for patient and public
involvement and empowerment need to be promoted and coordinated.
A PDF of the White Paper: Clinical Research can be downloaded or a printed copy can be ordered free of charge on
the SAMS website. The website also contains information on creating a
national coordination platform to strengthen the interaction between all public
stakeholders of clinical research and integrating the perspective of public
health.
0 Comments
Add a new comment